AnGes, Vical deal

Vical and AnGes' GenomIdea Inc. subsidiary partnered to develop a DNA vaccine using Vical's Vaxfectin adjuvant against pandemic influenza for use in livestock. GenomIdea will manufacture the vaccine ...